Nobel laureate David Baker leads initiative to engineer synthetic proteins

The short version

• Nobel laureate David Baker is serving as chief scientific officer for AI BioDesign, an initiative run by the Allen Institute, the University of Washington, and the Fred Hutchinson Cancer Center.[Wired]
• The effort aims to computationally model and design treatments quickly, targeting goals such as engineering disease cures within weeks instead of decades.[Wired]
• To counter biosecurity risks, Baker advocates tracking and logging all manufactured synthetic DNA sequences alongside their creators.[Wired]

Key facts

• David Baker shared the 2024 Nobel Prize in Chemistry for research in computational protein design.[Wired]
• The AI BioDesign initiative is run collaboratively by the Allen Institute, the University of Washington, and the Fred Hutchinson Cancer Center.[Wired]
• Baker serves as chief scientific officer at AI BioDesign.[Wired]
• Baker stated that computational design enables scientists to evaluate many risks prior to synthesizing molecules.[Wired]
• Baker stated his team aims to develop cures for new diseases in weeks rather than decades.[Wired]
• Baker recommended mandatory monitoring and logging of manufactured synthetic DNA sequences and creators to deter misuse.[Wired]

Sources

Outlet counts describe coverage, not independent confirmation. Reports may share a wire service or original source.

• He Won the Nobel Prize for Protein Design. Now He Uses AI to Create Molecules Not Found in NatureWired metered